MM

Matthew W. Martin

VH Valo Health: 5 patents #8 of 38Top 25%
FT Forma Therapeutics: 4 patents #1 of 41Top 3%
📍 Indianapolis, IN: #7 of 483 inventorsTop 2%
🗺 Indiana: #40 of 3,524 inventorsTop 2%
Overall (2022): #9,883 of 548,613Top 2%
9
Patents 2022

Issued Patents 2022

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11535618 Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Steven Mischke, David Richard +1 more 2022-12-27
11535607 Isoindolines as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Bingsong Han, Aleksandra Rudnitskaya +1 more 2022-12-27
11345672 Methods using HDAC11 inhibitors Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, Bingsong Han +6 more 2022-05-31
11299484 Inhibiting fatty acid synthase (FASN) Mary-Margaret Zablocki, Scot Richard Mente, Christopher J. Dinsmore, Zhongguo Wang, Xiaozhang Zheng 2022-04-12
11279681 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2022-03-22
11274085 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2022-03-15
11274084 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2022-03-15
11267805 Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone George P. Luke, Stephen Hubbs, Shawn Schiller, Robert Wenslow, Yawei Shi +1 more 2022-03-08
11247987 Inhibiting ubiquitin specific peptidase 30 Justin Andrew Caravella, Bingsong Han, Cuixian Liu, Stephanos Ioannidis, Alexandre Joseph Buckmelter +3 more 2022-02-15